TuHURA Biosciences, Inc.
HURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $117 | $0 | $0 | $0 |
| Gross Profit | -$117 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $13,335 | $9,402 | $7,929 | $4,879 |
| G&A Expenses | $0 | $4,145 | $2,005 | $2,376 |
| SG&A Expenses | $4,197 | $4,145 | $2,005 | $2,376 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $16,218 | $0 | $0 |
| Operating Expenses | $17,533 | $29,765 | $9,934 | $7,255 |
| Operating Income | -$17,649 | -$29,765 | -$9,934 | -$7,255 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$4,033 | $448 | $566 | $238 |
| Pre-Tax Income | -$21,682 | -$29,317 | -$9,368 | -$7,017 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21,682 | -$29,317 | -$9,368 | -$7,017 |
| % Margin | – | – | – | – |
| EPS | -1.214 | -11.291 | -324.485 | -903.035 |
| % Growth | 89.3% | 96.5% | 64.1% | – |
| EPS Diluted | -1.214 | -11.291 | -324.485 | -903.035 |
| Weighted Avg Shares Out | 18,663 | 753 | 46 | 28 |
| Weighted Avg Shares Out Dil | 18,663 | 753 | 46 | 28 |
| Supplemental Information | – | – | – | – |
| Interest Income | $362 | $90 | $57 | $0 |
| Interest Expense | $4,138 | $19 | $0 | $629 |
| Depreciation & Amortization | $117 | $177 | $373 | $381 |
| EBITDA | -$17,427 | -$29,121 | -$9,561 | -$6,007 |
| % Margin | – | – | – | – |